MicroPort Orthopedics Announces Launch of its Evolution® NitrX™ Medial-Pivot Knee System
June 26, 2019
ARLINGTON, Tenn.–(BUSINESS WIRE)–MicroPort Orthopedics, a medical device company that develops and manufactures cutting edge joint replacement implants designed to help patients achieve full function faster, announced the launch of the Evolution® NitrX™ Medial-Pivot Knee System.
The MicroPort Orthopedics medial-pivot knee system now stands on over 20 years of clinically demonstrated success with its novel medial-pivot design built on the evidence of the natural stability and kinematic motion of the knee.
The Evolution® NitrX™ Medial-Pivot Knee features a titanium niobium nitride (TiNbN) coating that has been shown in simulated clinical testing to reduce the release of cobalt (Co), chromium (Cr), molybdenum (Mb), and nickel (Ni) ions common in standard CoCr implants.1 The Evolution®NitrX™ Medial-Pivot Knee builds upon the same medial-pivot legacy of 95% patient satisfaction with 98.8% survivorship at 17 years.2
“I see a dramatic difference in patients treated with the Evolution® Medial-Pivot Knee in terms of pain and recovery. When I see these patients at four or six weeks, they’re just at a different stage of recovery than I was seeing with my previous patients treated with traditional implants,” says Russell Nevins, MD, Fellowship-Trained Orthopedic Surgeon at Desert Orthopedic Center in Las Vegas, NV. “With the Evolution® NitrX™ knee, we now have the ability to deliver the benefit of the medial-pivot design to a broader array of patients.”
About MicroPort Orthopedics
Established in January 2014, MicroPort Orthopedics Inc. is the fourth largest multinational producer of orthopedic products and a proud member of the MicroPort Scientific Corporation family of companies. From its headquarters in Arlington, Tennessee, MicroPort Orthopedics develops, produces, and distributes innovative OrthoRecon products. The company’s U.S.-based manufacturing and logistics capabilities deliver high quality hip and knee products to patients and their doctors in over 60 countries, including the U.S., EMEA, Japanese, Latin American and China markets. For more information about MicroPort Orthopedics, visit https://www.microportortho.com/.
MicroPort Scientific Corporation is a leading medical device company focused on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 20 seconds in thousands of major hospitals around the world, MicroPort maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient-oriented global enterprise that improves and reshapes patient lives through application of innovative science and technology. For more information, please refer to: http://www.microport.com.
Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words “believe,” “intend,” “expect,” “anticipate,” “project,” “estimate,” “predict,” “is confident,” “has confidence” and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort’s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.
This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.
- MicroPort Orthopedics Data on File.
- George A. Macheras et al. “A long term clinical outcome of the Medial Pivot Knee Arthroplasty System.” The Knee Journal, Published: January 29, 2017.
All rights reserved.
Copyright © 2019 MicroPort Orthopedics